Shanghai Bio-heart Biological Technology Co., Ltd. announced at the AGM held on June 27, 2022 that the company approved reappointment of Ernst & Young as auditor for a term until the conclusion of the next annual general meeting of the Company.
Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 HKD | +4.84% | -3.47% | -42.98% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.98% | 57.8M | |
+12.59% | 128B | |
-10.58% | 10.66B | |
-0.39% | 8.55B | |
+13.56% | 7.1B | |
+25.94% | 5.06B | |
+6.93% | 3.4B | |
-1.64% | 3.08B | |
-11.96% | 2.11B | |
-7.25% | 2.03B |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Shanghai Bio-Heart Biological Technology Co., Ltd. Approves Reappointment of Ernst & Young as Auditor